FBT First Trust NYSE Arca Biotechnology Index Fund
Holds 31 stocks in biotech and genomics, 24% of its weight in S&P 500 companies
FBT holds 31 stocks, and 76% of its weight is outside the S&P 500.
Key facts
ETFIQ Off-Index Score
64.2joint 121st of 349
FBT shares 7 of its 31 holdings with the S&P 500. Only 0.9% of its weight overlaps the index.
How much of it is not the index it is sold as an alternative to?
That is the share of the 349 thematic ETFs with a holdings filing sitting at or below FBT. A position in this set, not a rating: it moves when the set moves, and it is not a figure to average against another desk's.
1st of 12 biotech and genomics ETFs by net assets
Period by period
| Window | Total return | S&P 500 | Gap to S&P 500 | Gap to Nasdaq-100 |
|---|---|---|---|---|
| 3 months | +16.1% | +3.3% | +12.8 pts | +16.9 pts |
| 6 months | +35.9% | +16.0% | +19.9 pts | +15.2 pts |
| 1 year | +46.5% | +17.5% | +29.1 pts | +23.6 pts |
| 3 years | +72.4% | +77.9% | −5.5 pts | −22.7 pts |
| Since launch | +825.9% | +804.4% | +21.5 pts | −848.0 pts |
In plain words
The top ten holdings are 38% of the fund across 31 positions, as published by its issuer for Sep 10, 2026. Over the year to Sep 11, 2026 the fund returned +46.5% with distributions reinvested against +17.5% for the S&P 500, so a holder was ahead by 29.1 pts.
| Theme (ETFIQ, editorial) | Biotech and genomics |
|---|---|
| Launched | Jan 4, 2010 |
| Already in the S&P 500, by weight (ETFIQ) | 24.0% |
| Active share vs the S&P 500 (ETFIQ) | 99.1% |
| Already in the Nasdaq-100, by weight (ETFIQ) | 16.6% |
| Active share vs the Nasdaq-100 (ETFIQ) | 97.5% |
| Top ten holdings weight | 37.8% |
| Holdings | 31 |
| Holdings as of (the issuer’s daily file) | Sep 10, 2026 |
| Top holdings | Halozyme Therapeutics, Inc. 4.4%, Corcept Therapeutics Inc. 4.0%, NeoGenomics, Inc. 4.0%, Natera, Inc. 3.8%, Regeneron Pharmaceuticals, Inc. 3.8%, BeOne Medicines Ltd. (ADR) 3.6%, Repligen Corporation 3.6%, argenx SE (ADR) 3.5%, Gilead Sciences, Inc. 3.5%, Genmab A/S (ADR) 3.5% |
| Net assets (SEC filing, whole fund, as filed for Jun 30, 2026) | $2.8bn |
| Below its all-time high (ETFIQ) | −4.4% |
| Expense ratio (485BPOS XBRL, Apr 30, 2026) | 0.55% |
| Fee for the part that differs from the S&P 500, active expense ratio (ETFIQ) | 0.55% |
| Closest funds by holdings overlap | PBE 52%, BBH 44%, IBBQ 33%, BBP 30%, BMED 27% |
Holdings from the file the issuer publishes daily; overlap and active share computed by ETFIQ against the IVV and QQQM books; returns from Tiingo end-of-day prices with distributions reinvested. How these figures are computed
Questions people ask
- How much of FBT is in S&P 500 companies?
- By its holdings published by its issuer for Sep 10, 2026, 24% of FBT by weight is stocks the S&P 500 already holds. Its active share against the index is 99%, so that share is the part doing something different.
- What does FBT hold?
- 31 positions as published by its issuer for Sep 10, 2026, with the top ten at 38% of the fund. The largest are Halozyme Therapeutics, Inc. at 4.4%, Corcept Therapeutics Inc. at 4.0%, NeoGenomics, Inc. at 4.0%.
- Has FBT beaten the S&P 500?
- Over the year to Sep 11, 2026 FBT returned +46.5% with distributions reinvested, against +17.5% for the S&P 500, so it finished ahead of the index by 29.1 points.
- What does FBT cost?
- The prospectus expense ratio is 0.55% a year. Because 99% of the fund differs from the S&P 500, the fee on that differing part works out at 0.55%.
The words on this page
- Active share
- The part of the fund doing something the index is not, as a percentage. It is the part a fee is actually buying.
- Weight overlap
- The share of money two portfolios hold in the same securities at the same weight. Above 50%, holding both is close to holding one of them twice.
- Already in the index
- The fund’s weight in securities the S&P 500 holds at all. A fund can be made entirely of index names and still have high active share, because it holds them at very different weights.
- Top ten
- What the ten largest positions add up to. The higher it is, the more the fund is a bet on a few companies rather than a theme.
Every term used here, defined in full on the thematic ETFs vocabulary page.
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Funds near this one
Put this on your own page
The difference bar for FBT, redrawn every trading night. Free to use with the credit link.
Where FBT is written about
Use this data, or open the live card
Open FBT live on ETFIQ, where the figures refresh with the data.
Cite this page. ETFIQ, FBT, thematic ETFs, data as of Sep 11, 2026. https://etfiq.com/funds/FBT Free to use with attribution; the underlying files are at Open data.